No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Melflufen plus dexamethasone showed superior progression-free survival over standard of care in multiple myeloma refractory to lenalidomide

byKathleen Lau

January 27, 2022

in StudyGraphics

Reading Time: 1 min read

Shorter antibiotic course effective in children with community acquired pneumonia

RelatedReports

$The STORM trial: treatment refractory multiple myeloma patients experience response with selinexor$

Chronic Disease

Talquetamab and teclistamab combination improved response in relapsed multiple myeloma

March 6, 2025

StudyGraphics

#VisualAbstract: Daratumumab Reduces Risk of Progression in High-Risk Smoldering Multiple Myeloma

December 26, 2024

Phase III trial shows survival benefit for early multiple myeloma

Pharma

Sanofi’s Sarclisa approved as first-line for transplant-ineligible multiple myeloma patients

October 22, 2024

Nonleg venous thromboses associated with PE, longer ICU stay

Chronic Disease

Pomalidomide effective in reducing epistaxis in hereditary hemorrhagic telangiectasia

October 11, 2024

Risk of myocarditis after receiving mRNA-based COVID-19 vaccines

Cancer to surpass heart disease as leading cause of death in the U.S. for higher-income persons

Longer onset-to-treatment time for subarachnoid hemorrhage is associated with increased 12-month all-cause mortality

Bystander intervention may improve survival after exercise-related sudden cardiac arrest

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports